Page last updated: 2024-10-30

letrozole and Morbid Obesity

letrozole has been researched along with Morbid Obesity in 2 studies

Research Excerpts

ExcerptRelevanceReference
"To examine whether aromatase inhibition with Letrozole can normalize serum testosterone levels in severely obese men with hypogonadotropic hypogonadism."9.11Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. ( de Boer, H; Jansen, M; Ruinemans-Koerts, J; Verschoor, L, 2005)
"To examine whether aromatase inhibition with Letrozole can normalize serum testosterone levels in severely obese men with hypogonadotropic hypogonadism."5.11Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. ( de Boer, H; Jansen, M; Ruinemans-Koerts, J; Verschoor, L, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loves, S1
de Jong, J1
van Sorge, A1
Telting, D1
Tack, CJ1
Hermus, A1
Westerterp, K1
de Boer, H2
Verschoor, L1
Ruinemans-Koerts, J1
Jansen, M1

Trials

2 trials available for letrozole and Morbid Obesity

ArticleYear
Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia.
    European journal of endocrinology, 2013, Volume: 169, Issue:5

    Topics: Adult; Androgens; Aromatase Inhibitors; Blood Glucose; Body Composition; Body Mass Index; Bone Densi

2013
Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:3

    Topics: Aromatase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Gon

2005